Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hair Cells, Auditory | 3 | 2017 | 63 | 0.700 |
Why?
|
| Anion Transport Proteins | 1 | 2016 | 30 | 0.510 |
Why?
|
| Cell Membrane | 1 | 2016 | 464 | 0.440 |
Why?
|
| Antioxidants | 1 | 2015 | 355 | 0.390 |
Why?
|
| Trehalose | 2 | 2018 | 20 | 0.280 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2527 | 0.280 |
Why?
|
| Cerebral Palsy | 1 | 2023 | 80 | 0.190 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2020 | 16 | 0.170 |
Why?
|
| COUP Transcription Factor I | 1 | 2020 | 91 | 0.170 |
Why?
|
| Disabled Persons | 1 | 2020 | 92 | 0.160 |
Why?
|
| Acetylglucosaminidase | 1 | 2018 | 12 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2018 | 177 | 0.150 |
Why?
|
| Hearing Loss | 2 | 2017 | 136 | 0.150 |
Why?
|
| Length of Stay | 1 | 2023 | 1306 | 0.140 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 174 | 0.140 |
Why?
|
| Memory Disorders | 1 | 2020 | 229 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 4417 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 273 | 0.140 |
Why?
|
| Retinal Degeneration | 1 | 2018 | 93 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 395 | 0.140 |
Why?
|
| Mental Health Services | 1 | 2020 | 259 | 0.140 |
Why?
|
| Autophagy | 2 | 2018 | 395 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 290 | 0.130 |
Why?
|
| Electric Capacitance | 1 | 2016 | 13 | 0.130 |
Why?
|
| Gerbillinae | 1 | 2016 | 55 | 0.130 |
Why?
|
| Hippocampus | 2 | 2020 | 824 | 0.130 |
Why?
|
| Ion Transport | 1 | 2016 | 52 | 0.130 |
Why?
|
| Nonlinear Dynamics | 1 | 2016 | 51 | 0.130 |
Why?
|
| Hair Cells, Auditory, Outer | 1 | 2016 | 69 | 0.130 |
Why?
|
| Cochlea | 1 | 2016 | 87 | 0.120 |
Why?
|
| Electrophysiology | 1 | 2016 | 272 | 0.120 |
Why?
|
| Doxycycline | 1 | 2016 | 117 | 0.120 |
Why?
|
| Cell Survival | 2 | 2015 | 820 | 0.120 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 283 | 0.120 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 162 | 0.120 |
Why?
|
| Membrane Potentials | 1 | 2016 | 307 | 0.120 |
Why?
|
| Alleles | 2 | 2017 | 1615 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 361 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 377 | 0.120 |
Why?
|
| Movement Disorders | 1 | 2017 | 222 | 0.110 |
Why?
|
| Animals | 10 | 2020 | 34304 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 493 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 249 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2016 | 738 | 0.110 |
Why?
|
| Organ of Corti | 1 | 2013 | 26 | 0.110 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2016 | 310 | 0.110 |
Why?
|
| Mice | 7 | 2020 | 17740 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 373 | 0.100 |
Why?
|
| Disease Progression | 1 | 2018 | 2084 | 0.100 |
Why?
|
| Neurons | 3 | 2017 | 1933 | 0.090 |
Why?
|
| Gene Expression | 1 | 2016 | 1554 | 0.090 |
Why?
|
| Depression | 1 | 2020 | 1232 | 0.090 |
Why?
|
| Repressor Proteins | 2 | 2013 | 827 | 0.090 |
Why?
|
| Embryonic Development | 1 | 2013 | 211 | 0.090 |
Why?
|
| Inflammation | 1 | 2018 | 1447 | 0.090 |
Why?
|
| Chromosome Disorders | 1 | 2013 | 311 | 0.090 |
Why?
|
| Brain | 3 | 2018 | 3014 | 0.090 |
Why?
|
| Aging | 1 | 2017 | 1181 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 2013 | 653 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 1006 | 0.070 |
Why?
|
| Time Factors | 2 | 2016 | 6302 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 960 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1130 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3175 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 2414 | 0.060 |
Why?
|
| Insect Hormones | 1 | 2005 | 8 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2018 | 680 | 0.060 |
Why?
|
| Astrocytes | 2 | 2018 | 251 | 0.060 |
Why?
|
| Neuropeptides | 1 | 2005 | 113 | 0.060 |
Why?
|
| Rehabilitation Centers | 1 | 2023 | 27 | 0.050 |
Why?
|
| Muscle Relaxants, Central | 1 | 2023 | 34 | 0.050 |
Why?
|
| Baclofen | 1 | 2023 | 41 | 0.050 |
Why?
|
| Rhizotomy | 1 | 2023 | 17 | 0.050 |
Why?
|
| Orthopedic Procedures | 1 | 2023 | 69 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2023 | 432 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2020 | 3756 | 0.050 |
Why?
|
| Humans | 5 | 2023 | 125110 | 0.040 |
Why?
|
| Physical and Rehabilitation Medicine | 1 | 2020 | 34 | 0.040 |
Why?
|
| Inpatients | 1 | 2023 | 497 | 0.040 |
Why?
|
| Male | 7 | 2023 | 61443 | 0.040 |
Why?
|
| Mucopolysaccharidosis III | 1 | 2018 | 13 | 0.040 |
Why?
|
| Vacuoles | 1 | 2018 | 25 | 0.040 |
Why?
|
| Retinal Bipolar Cells | 1 | 2018 | 38 | 0.040 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2018 | 82 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 490 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2017 | 122 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 39 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 103 | 0.030 |
Why?
|
| Serine | 1 | 2017 | 175 | 0.030 |
Why?
|
| Lysosomes | 1 | 2018 | 239 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 486 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 166 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 168 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 365 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 368 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2017 | 808 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1496 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 413 | 0.030 |
Why?
|
| Female | 5 | 2023 | 66704 | 0.030 |
Why?
|
| Labyrinth Supporting Cells | 1 | 2013 | 4 | 0.030 |
Why?
|
| Ethylnitrosourea | 1 | 2013 | 7 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 1640 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 157 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2017 | 879 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 114 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1112 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 140 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2017 | 887 | 0.020 |
Why?
|
| Chromosomes | 1 | 2013 | 207 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 971 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2013 | 363 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1017 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 455 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 1019 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 989 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2023 | 12272 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2023 | 14152 | 0.020 |
Why?
|
| Proteins | 1 | 2013 | 1040 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 2815 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 4408 | 0.020 |
Why?
|
| Orthoptera | 1 | 2005 | 2 | 0.020 |
Why?
|
| Juvenile Hormones | 1 | 2005 | 4 | 0.020 |
Why?
|
| Manduca | 1 | 2005 | 6 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2023 | 16339 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1910 | 0.020 |
Why?
|
| Neurosecretory Systems | 1 | 2005 | 23 | 0.020 |
Why?
|
| Adolescent | 1 | 2023 | 19414 | 0.020 |
Why?
|
| Insecta | 1 | 2005 | 58 | 0.020 |
Why?
|
| United States | 1 | 2020 | 10884 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2005 | 188 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 4597 | 0.010 |
Why?
|
| Child | 1 | 2023 | 24610 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 4270 | 0.010 |
Why?
|
| Peptides | 1 | 2005 | 812 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1704 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1685 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1958 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 1026 | 0.010 |
Why?
|